[Holisal in the complex treatment of periodontal disease].
The aim of our research was to evaluate efficiency of medicine Cholisal in complex treatment of periodontitis. During the research 36 patients with periodontitis (from 18 to 36 years old) were examined and treated. The patients were divided into 3 groups according to severity of periodontitis. Each group included 12 patients. For studying the efficiency of treatment both objective and subjective data was used. In case of mild severity of disease clinical indices were: HI=2,1+/-0,75; Ghi=1,4+/-0,67; Gi=1,7+/-0,78, PI=0,8+/-0,34. In case of moderate severity of disease clinical indices were: HI=2,57+/-1,02; GHI=2,18+/-0,81; GI=1,95+/-0,8, PI=3,9+/-1,1. In case of severe disease - HI=3,9+/-1,25, GHI=2,5+/-0,8, GI=2,9+/-1,2, PI=7,8+/-1,62. Clinical study has shown that Cholisal enables successful treatment of periodontitis. It has prolonged, antiinflamatory, deodorant and analgesic effect. Our investigation revealed that xolisale can be recommended in complex treatment of periodontal disease.
Iverieli
M
M
Tbilisi State Medical University, Department of Therapeutie Stomatology, Tbilisi, Georgia.
Abashidze
N
N
Gogishvili
Kh
Kh
D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002482:Cellulose / Q000031:analogs & derivatives / Q000627:therapeutic use; D002794:Choline / Q000031:analogs & derivatives / Q000627:therapeutic use; D005990:Glycerol / Q000031:analogs & derivatives / Q000627:therapeutic use; D006801:Humans; D009910:Oral Hygiene; D010510:Periodontal Diseases / Q000188:drug therapy / Q000628:therapy*; D012459:Salicylates / Q000627:therapeutic use; D012720:Severity of Illness Index
D000900:Anti-Bacterial Agents; C529917:Holisal; D012459:Salicylates; D002482:Cellulose; D002794:Choline; D005990:Glycerol